British Columbia Drug and Poison Information Centre (BC DPIC)
Healthcare Professionals
Health Headlines
Weblinks
About DPIC
Contact
Terms & Conditions
Index
Search this site:
Poison Information
Emergency Line:
1-800-567-8911 or
604-682-5050
General Information
Prevention Tips
Prevention Material
Fact Sheets
BC Poison Control
Springtime Hazards
Holiday Hazards
Poisonings FAQ
Drug Information
BC Healthcare Professionals
Drug Information Line
1-866-298-5909 or
604-806-9104
(Mon - Fri, 9am to 4pm)
Drug Product Listings
Safe Medication Use
Publications
DI Perpectives Newsletter
Drug Information Reference
Home
›
Drug Product Listings
› Degarelix
Degarelix
Trade Name:
Firmagon
Manufacturer/Distributor:
Ferring
1-800-263-4057
Classification:
Antineoplastic agent
ATC Class:
L02BX02 - Degarelix
Status:
active
Notice of Compliance (yyyy/mm/dd):
2009/11/16
Date Marketed in Canada (yyyy/mm/dd):
2009/11
Presentation:
Injection: 80 mg/vial, DIN 02337029
Injection: 120 mg/vial, DIN 02337037
Comments:
Gonadotropin-releasing receptor antagonist for testosterone suppression in patients with advanced hormone-dependent prostate cancer in whom androgen deprivation is warranted.
Posted
Updated
2000-01-30 08:59
2010-01-30 09:04
Back to:
Drug Product Listings
Browse by keywords:
antineoplastic agents
degarelix
prostatic neoplasms
prostatic neoplasms
-
A
+
A
E-mail Subscriptions
DI Perspectives Newsletter
Email:
*
Subscribe
Unsubscribe